OFM
SNTI icon

Omega Fund Management’s Senti Biosciences Holdings SNTI Stock Holding History

Omega Fund Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,579
Closed -$129K – 12
2023
Q4 		$129K Hold
19,579
– – 0.1% 14
2023
Q3 		$80.9K Hold
19,579
– – 0.07% 12
2023
Q2 		$123K Hold
19,579
– – 0.07% 12
2023
Q1 		$231K Hold
19,579
– – 0.15% 14
2022
Q4 		$276K Hold
19,579
– – 0.09% 16
2022
Q3 		$425K Hold
19,579
– – 0.16% 19
2022
Q2 		$386K Buy
+19,579
New +$1.57M 0.12% 21

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
8GI
8VC GP I Austin, Texas $42.8M AUM 15.67% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $621M AUM 34.06% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Omega Fund Management's SNTI Position: Q1 2024 in Review

Omega Fund Management sold out of Senti Biosciences Holdings (SNTI) in Q1 2024, closing a stake of 19,579 shares — an estimated $129K sold.

Omega Fund Management first reported a position in SNTI in Q2 2022 and held it in 7 quarters. The position peaked at $425K in Q3 2022. 27 funds tracked by Wall St. Rank hold SNTI as of Q1 2024.

  • Omega Fund Management reported no remaining Senti Biosciences Holdings position as of Q1 2024 after selling out during the quarter.
  • Omega Fund Management sold 19,579 Senti Biosciences Holdings shares in Q1 2024, an estimated $129K.
  • Omega Fund Management first reported a position in Senti Biosciences Holdings in Q2 2022 and held it in 7 quarters.
  • Omega Fund Management's Senti Biosciences Holdings position peaked at $425K in Q3 2022.
  • 27 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2024.

Based on Omega Fund Management's 13F filing for Q1 2024, filed 14 May 2024.